Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Hubble

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Neurology|April 1, 1995
Botulinum toxin treatment of essential head tremorR Pahwa, K Busenbark, E F Swanson-Hyland, et al.
Neuroepidemiology|January 1, 1996
Risk factors for dementia in Parkinson's disease: effect of educationS L Glatt, J P Hubble, K Lyons, et al.
Clinical Neuropharmacology|August 1, 1995
Pramipexole in patients with early Parkinson's diseaseJ P Hubble, W C Koller, N R Cutler, et al.
Neurology|November 26, 2003
Vagus nerve stimulation for essential tremor: a pilot efficacy and safety trialA Handforth, W G Ondo, S Tatter, et al.
Neuroepidemiology|May 21, 1998
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementiaJ P Hubble, J H Kurth, S L Glatt, et al.
Neurology|May 1, 1991
Does a long preclinical period occur in Parkinson's disease?W C Koller, J W Langston, J P Hubble, et al.
Geriatrics|August 1, 1991
Does a long preclinical period occur in Parkinson's disease?W C Koller, J W Langston, J P Hubble, et al.
Neurology|April 1, 1996
Normal distribution of apolipoprotein E alleles in progressive supranuclear palsyA Anouti, K Schmidt, K E Lyons, et al.
Annals of Neurology|February 1, 1995
Apolipoprotein E genotypes in Parkinson's disease with and without dementiaW C Koller, S L Glatt, J P Hubble, et al.
Neurology|June 9, 2004
Apolipoprotein E controls the risk and age at onset of Parkinson diseaseY J Li, M A Hauser, W K Scott, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Neurology|April 1, 1995
Botulinum toxin treatment of essential head tremorR Pahwa, K Busenbark, E F Swanson-Hyland, et al.
Neuroepidemiology|January 1, 1996
Risk factors for dementia in Parkinson's disease: effect of educationS L Glatt, J P Hubble, K Lyons, et al.
Clinical Neuropharmacology|August 1, 1995
Pramipexole in patients with early Parkinson's diseaseJ P Hubble, W C Koller, N R Cutler, et al.
Neurology|November 26, 2003
Vagus nerve stimulation for essential tremor: a pilot efficacy and safety trialA Handforth, W G Ondo, S Tatter, et al.
Neuroepidemiology|May 21, 1998
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementiaJ P Hubble, J H Kurth, S L Glatt, et al.
Neurology|May 1, 1991
Does a long preclinical period occur in Parkinson's disease?W C Koller, J W Langston, J P Hubble, et al.
Geriatrics|August 1, 1991
Does a long preclinical period occur in Parkinson's disease?W C Koller, J W Langston, J P Hubble, et al.
Neurology|April 1, 1996
Normal distribution of apolipoprotein E alleles in progressive supranuclear palsyA Anouti, K Schmidt, K E Lyons, et al.
Annals of Neurology|February 1, 1995
Apolipoprotein E genotypes in Parkinson's disease with and without dementiaW C Koller, S L Glatt, J P Hubble, et al.
Neurology|June 9, 2004
Apolipoprotein E controls the risk and age at onset of Parkinson diseaseY J Li, M A Hauser, W K Scott, et al.
Pageof 5